Get App

WhatsApp Channel

Tune in to know the latest updates on the health industry

ETHealth Newsletters

Explore and Subscribe to our Daily Newsletters

Follow Us

Get updates of events and latest news from ETHealth on LinkedIn.

Novartis plans to close a Sandoz plant in North Carolina

It said the decision to close the site had come before it announced a strategic review of Sandoz, which it plans to spin off to sharpen the group's focus on patented prescription medicines.
  • Updated On Sep 10, 2022 at 03:54 PM IST
Read by: 100 Industry Professionals
Reader Image Read by 100 Industry Professionals
Zurich: Pharmaceuticals company Novartis plans to close a Sandoz generics plant in Wilson, North Carolina, around the end of 2023, it said on Friday, citing the inability to use the U.S. site to full capacity.

The site with about 246 employees specialises in producing pharmaceutical oral solid dosage products for distribution mostly in U.S. and Canadian markets.

It said the decision to close the site had come before it announced a strategic review of Sandoz, which it plans to spin off to sharpen the group's focus on patented prescription medicines.
  • Published On Sep 10, 2022 at 03:45 PM IST
Be the first one to comment.
Comment Now

COMMENTS

Comment Now Read Comment (1)

Join the community of 2M+ industry professionals

Subscribe to our newsletter to get latest insights & analysis.

Download ETHealthworld App

  • Get Realtime updates
  • Save your favourite articles
Scan to download App
image